Verastem Oncology’s Collaboration with GenFleet Therapeutics

Ropes & Gray advised Verastem Oncology on the deal.Verastem Oncology (Nasdaq: VSTM) announced that the company has entered into a discovery and development collaboration with GenFleet…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here